Kelvan Cheung
Kelvan Cheung

Kelvan Cheung

Partner

LOCATION:
Hong Kong
DIRECT:
+852 2825 9279

Kelvan Cheung

Partner

LOCATION:
Hong Kong
DIRECT:
+852 2825 9279


+ Add to Binder

Kelvan is a Partner in Deacons’ Corporate Finance Group. Kelvan has an extensive experience in the corporate finance field. He advises on initial public offerings, mergers and acquisitions, private equity transactions as well as regulatory compliance matters.

Kelvan’s experience includes advising sponsors and issuers on a number of global offerings and listings on the Hong Kong Stock Exchange, including:

  • Asia Grocery Distribution Limited
  • Beijing Chunlizhengda Medical Instruments Co., Ltd. (H-share listing on the Main Board of Hong Kong Stock Exchange)
  • Chiho-Tiande Group Limited
  • China Animal Healthcare Ltd. (listing by way of introduction on the Main Board of Hong Kong Stock Exchange)
  • China Art Financial Holdings Limited
  • China Saite Group Company Limited
  • Global New Material International Holdings Limited
  • Grand Ming Group Holdings Limited
  • G.H.Y. Culture & Media Holding Co., Limited (listing on the Main Board of Singapore Exchange)
  • Huisheng International Holdings Limited
  • Kinetix Systems Holdings Limited
  • KOS International Holdings Limited
  • Max Sight Group Holdings Limited
  • MBV International Limited
  • Most Kwai Chung Limited
  • Niche-Tech Group Limited
  • Sinoref Holdings Limited
  • SiS Mobile Holdings Limited (spin-off and listing on the Main Board of Hong Kong Stock Exchange)
  • Xin Point Holdings Limited
  • ZACD Group Limited

 

Kelvan’s experience of capital markets, mergers and acquisitions and private equity includes advising:

EC Healthcare (SEHK Stock Code: 2138) on its placing of new shares through Haitong International Securities Company Limited (as placing agent) to raise up to approximately 500 million. The placees include Dr. Cheng Chi Kong, Adrian JP and Aspex Master Fund

EC Healthcare on its acquisition of Pathlab Medical Laboratories Limited at an aggregate consideration of approximately HK$575.5 million

EC Healthcare on its acquisition of The New Medical Center Limited at an aggregate consideration of approximately HK$136 million and cash contribution of HK$100 million into the holding company of The New Medical Center Limited

EC Healthcare on its acquisition of Hong Kong Pain and Wellness Solution Limited at a consideration of approximately HK$106.2 million

Beijing Jianguang Asset Management Co. Ltd., a subsidiary of JIC Capital Management Ltd. (a Chinese state-owned investment company), on a US$1.8 billion acquisition of power amplifier business from NXP Semiconductors N.V. (NASDAQ: NXPI). This transaction was one of the largest outbound technology deals of 2015 and won “Deal of the Year in 2015” by China Business Law Journal

An undisclosed client in its proposed bid for Nanyang Commercial Bank, Limited. This transaction involved the sale by BOC Hong Kong of its subsidiary Nanyang Commercial Bank, Limited for HK$68 billion through public bidding process at the Beijing Financial Assets Exchange

Haitong International Securities Company Limited, acting as one of the underwriters, in relation to the open offer of shares by Hua Han Bio-Pharmaceutical Holdings Limited (SEHK Stock Code: 587), raising up to approximately HK$3,400 million

National Agricultural Holdings Limited (SEHK Stock Code: 1236) on the placing and subscription of new shares raising gross proceeds up to approximately HK$1,125 million

Winshine Entertainment & Media Holding Company Limited (SEHK Stock Code: 209) on the proposed placing of new shares, bonds and convertible bonds and proposed acquisition of the right of control, economic interests, management and benefits of Beijing Weiying Times Technology Co., Ltd.

Orient Victory Real Estate Group Holdings Limited on its takeover of Orient Victory China Holdings Limited (formerly known as South China Holdings Limited)

Parko (Hong Kong) Limited (indirectly controlled by Hebei Supply and Marketing Cooperative, an administrative body of the People’s Government of Hebei Province of the PRC) on its takeover and subscription of convertible bonds of National Agricultural Holdings Limited (formerly known as Qianlong Technology International Holdings Limited)

Affluent Trade Ltd. on its acquisition from Morning Star Resources Limited the entire issued share capital of a group of wholly-owned companies of Morning Star Resources (SEHK Stock Code: 1051), constituting a very substantial acquisition of Moring Star Resources

I.T Limited (SEHK Stock Code: 999) on its acquisition of Nowhere Co., Ltd., a Japanese apparels company owns various fashion brand names including “A Bathing Ape”

Sino Polymer New Materials Co., Ltd. (SEHK Stock Code: 67) on the disposal of interests by its shareholders to Lumena Resources Corp., at an aggregate consideration of US$1,500 million, which constitutes a very substantial acquisition and a connected transaction for Lumena Resources Corp.

Ping An of China Asset Management in relation to the subscription of convertible redeemable preference shares of a company which is engaged in exploration and exploitation of coal seam gas

DBS Private Equity and SEAVI Advent Private Equity in their pre-IPO investments in Jintian Pharmaceutical Group Limited

DBS Private Equity in its investment in a PRC based solar panel manufacturer

Education

BSSc (Government & Public Administration), Chinese University of Hong Kong (2002)

LL.B., University of Nottingham, United Kingdom (2005)

P.C.LL., University of Hong Kong (2006)

 

Accolades

Asian Legal Business – Top 40 under 40 Lawyer (2016 edition)

IFLR100– Capital Markets (Equity) – Notable practitioner (2019 - 2022 edition)

Back